Browse Careers
Browse Investors

Bard Names Group Vice Presidents

MURRAY HILL, N.J.--(BUSINESS WIRE)--April 29, 2003--C. R. Bard, Inc. (NYSE:BCR) announced today that Brian P. Kelly and Amy S. Paul have each been named to the position of Group Vice President, effective June 1, 2003.

Kelly, 45, joined the company in 1983 as a territory sales manager for Bard's subsidiary, Davol Inc. He has held a succession of management positions including Vice President of Sales for Bard Access Systems, Inc. and Vice President and General Manager of Davol Inc. Since 1997, Kelly served as the President of Davol Inc. He holds a bachelor's degree in Marketing from Niagara University. As Group Vice President, his responsibilities will include the operations of Bard's Davol, Endoscopic Technologies and Electrophysiology businesses.

Paul, 51, came to Bard in 1982 as a senior product manager for Davol Inc. She has held positions of increasing responsibility in marketing including Vice President of Marketing for Bard's former Cardiopulmonary Division. She subsequently advanced through general management positions including President of the Interventional Products Division. Since 1997, she has been President of Bard Access Systems, Inc. She received a bachelor's degree in English and a master's degree in business with a concentration in marketing from Boston University. As Group Vice President, Paul will be responsible for the operations of Bard's international businesses.

William H. Longfield, chairman and chief executive officer, stated, "These appointments represent the next step in our executive transition plan. Brian Kelly and Amy Paul are experienced leaders who have played key roles in the results of two of our most successful businesses. With their experience in Bard's businesses, they will be great additions to our new senior management team."

C. R. Bard, Inc., ( headquartered in Murray Hill, New Jersey, is a leading multinational developer, manufacturer and marketer of health care products in the fields of vascular, urology, oncology and surgical specialty products.

This press release contains forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Please refer to our December 31, 2002 Form 10-K for a statement with regard to forward-looking statements, including disclosure of additional factors that could cause actual results to differ materially from those expressed or implied.

    CONTACT: C. R. Bard, Inc., Murray Hill
             Eric J. Shick (investor relations), 908/277-8413
             Holly P. Glass (media relations), 703/754-2848

    SOURCE: C. R. Bard, Inc. 


Primary Media Relations Contact

Scott Lowry
Vice President and Treasurer
C. R. Bard, Inc.
730 Central Avenue
Murray Hill, NJ 07974

Tel: 908-277-8365